Geron Corporation Investors: Company Investigated by the Portnoy Law Firm

Core Viewpoint - The Portnoy Law Firm has initiated an investigation into Geron Corporation for possible securities fraud, potentially leading to a class action lawsuit for investors who have incurred losses [1][3]. Group 1: Investigation Details - The investigation focuses on Geron Corporation's communications regarding the anticipated launch and growth potential of its drug Rytelo (imetelstat) [3]. - Allegations include that Geron misled investors by expressing confidence in the drug's market potential while downplaying risks related to monitoring requirements and competition [3]. Group 2: Investor Actions - Investors who have lost money are encouraged to contact attorney Lesley F. Portnoy for a complimentary case evaluation and to discuss their legal rights [2][4]. - The Portnoy Law Firm has a history of recovering over $5.5 billion for investors affected by corporate wrongdoing [4].